Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: OpinionHuman medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Status: OpinionHuman medicines European public assessment report (EPAR): Redemplo, plozasiran, Status: OpinionHuman medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Status: OpinionHuman medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion